Year | Number of companiesb | Number of drugs | Total sales ($000) | R&D spending ($000) (% sales) | Promotion spending ($000) (% sales) | Ratio of R&D to promotion spending | Number of companies spending more on promotion than on R&D |
---|---|---|---|---|---|---|---|
2013 | 22 | 46 | 12,761,798 | 565,670 (4.4) | 243,420 (1.9) | 2.32 | 9 |
2014 | 22 | 46 | 13,327,819 | 509,531 (3.8) | 242,401 (1.8) | 2.11 | 8 |
2015 | 22 | 45 | 13,215,385 | 487,223 (3.7) | 230,157 (1.7) | 2.18 | 9 |
2016 | 22 | 49 | 13,610,805 | 553,057 (4.1) | 258,363 (1.9) | 2.16 | 10 |